HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M300291-JLR200v1 45/6/1051    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Solaas, K. Articles by Alexson, S. E. H. Search for Related Content PubMed PubMed Citation Articles by Solaas, K. Articles by Alexson, S. E. H. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 45, 1051-1060, June 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology

Differential regulation of cytosolic and peroxisomal bile acid amidation by PPAR activation favors the formation of unconjugated bile acids

Karianne Solaas^*, B. Frode Kase^1,, Viet Pham, Krister Bamberg, Mary C. Hunt^* and Stefan E. H. Alexson^*

^* Division of Clinical Chemistry, Karolinska Institutet, Karolinska University Hospital at Huddinge, SE-141 86 Stockholm, Sweden
Department of Pediatric Research, Rikshospitalet, NO-0027 Oslo, Norway
Department of Molecular Biology, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden

¹ To whom correspondence should be addressed. e-mail: b.f.kase{at}klinmed.uio.no

In human liver, unconjugated bile acids can be formed by the action of bile acid-CoA thioesterases (BACTEs), whereas bile acid conjugation with taurine or glycine (amidation) is catalyzed by bile acid-CoA:amino acid N-acyltransferases (BACATs). Both pathways exist in peroxisomes and cytosol. Bile acid amidation facilitates biliary excretion, whereas the accumulation of unconjugated bile acids may become hepatotoxic. We hypothesized that the formation of unconjugated and conjugated bile acids from their common substrate bile acid-CoA thioesters by BACTE and BACAT is regulated via the peroxisome proliferator-activated receptor (PPAR). Livers from wild-type and PPAR-null mice either untreated or treated with the PPAR activator WY-14,643 were analyzed for BACTE and BACAT expression. The total liver capacity of taurochenodeoxycholate and taurocholate formation was decreased in WY-14,643-treated wild-type mice by 60% and 40%, respectively, but not in PPAR-null mice. Suppression of the peroxisomal BACAT activity was responsible for the decrease in liver capacity, whereas cytosolic BACAT activity was essentially unchanged by the treatment. In both cytosol and peroxisomes, the BACTE activities and protein levels were upregulated 5- to 10-fold by the treatment. These effects caused by WY-14,643 treatment were abolished in PPAR-null mice.

The results from this study suggest that an increased formation of unconjugated bile acids occurs during PPAR activation.

Abbreviations: BACAT, bile acid-CoA:amino acid N-acyltransferase; BACS, bile acid-CoA synthetase; BACTE, bile acid-CoA thioesterase; CA, cholic acid; CDCA, chenodeoxycholic acid; FXR, farnesoid X receptor; HNF-4, hepatocyte nuclear factor 4; LCA, lithocholic acid; PPAR, peroxisome proliferator-activated receptor ; PTE-2, peroxisomal acyl-CoA thioesterase 2; THCA, 3,7,12-trihydroxy-5ß-cholestanoic acid

Supplementary key words bile acid-coenzyme A:amino acid N-acyltransferase • bile acid-coenzyme thioesterase • peroxisome proliferator-activated receptor • farnesoid X receptor • cholestyramine

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. B. Rosen, B. D. Abbott, D. C. Wolf, J. C. Corton, C. R. Wood, J. E. Schmid, K. P. Das, R. D. Zehr, E. T. Blair, and C. Lau Gene Profiling in the Livers of Wild-type and PPAR{alpha}-Null Mice Exposed to Perfluorooctanoic Acid Toxicol Pathol, June 1, 2008; 36(4): 592 - 607. [Abstract] [Full Text] [PDF]

				S. Wiese, T. Gronemeyer, R. Ofman, M. Kunze, C. P. Grou, J. A. Almeida, M. Eisenacher, C. Stephan, H. Hayen, L. Schollenberger, et al. Proteomics Characterization of Mouse Kidney Peroxisomes by Tandem Mass Spectrometry and Protein Correlation Profiling Mol. Cell. Proteomics, December 1, 2007; 6(12): 2045 - 2057. [Abstract] [Full Text] [PDF]

				N. A. Styles, J. L. Falany, S. Barnes, and C. N. Falany Quantification and regulation of the subcellular distribution of bile acid coenzyme A:amino acid N-acyltransferase activity in rat liver J. Lipid Res., June 1, 2007; 48(6): 1305 - 1315. [Abstract] [Full Text] [PDF]

				S. Ferdinandusse, S. Denis, H. Overmars, L. Van Eeckhoudt, P. P. Van Veldhoven, M. Duran, R. J. A. Wanders, and M. Baes Developmental Changes of Bile Acid Composition and Conjugation in L- and D-Bifunctional Protein Single and Double Knockout Mice J. Biol. Chem., May 13, 2005; 280(19): 18658 - 18666. [Abstract] [Full Text] [PDF]

				H.-L. Fang, S. C. Strom, H. Cai, C. N. Falany, T. A. Kocarek, and M. Runge-Morris Regulation of Human Hepatic Hydroxysteroid Sulfotransferase Gene Expression by the Peroxisome Proliferator-Activated Receptor {alpha} Transcription Factor Mol. Pharmacol., April 1, 2005; 67(4): 1257 - 1267. [Abstract] [Full Text] [PDF]

				T. Hays, I. Rusyn, A. M. Burns, M. J. Kennett, J. M. Ward, F. J. Gonzalez, and J. M. Peters Role of peroxisome proliferator-activated receptor-{alpha} (PPAR{alpha}) in bezafibrate-induced hepatocarcinogenesis and cholestasis Carcinogenesis, January 1, 2005; 26(1): 219 - 227. [Abstract] [Full Text] [PDF]